Skip to main content
logo
BioAtla, Inc. (BCAB)
NASDAQ: BCAB · Real-Time Price · USD
3.370
-0.090 (-2.60%)
At close: Jul 24, 2026, 4:00 PM EDT
3.310
-0.060 (-1.78%)
After-hours: Jul 24, 2026, 4:10 PM EDT

BioAtla Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
-211--0.25
Revenue Growth
--81.82%----41.73%
Gross Profit
-211--0.25
Operating Income
-51-59.31-73.94-129.69-108.14-96.44
Net Income
-50.62-59.61-69.78-123.46-106.48-95.4
Earnings Per Share
-41.72-50.50-72.00-129.00-137.00-138.00
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
1.967.1249.05111.47215.51244.98
Total Debt
6.096.20.842.463.985.37
Net Cash (Debt)
-4.130.9248.21109.01211.53239.61
Net Cash Growth
--98.10%-55.77%-48.46%-11.72%1.57%
Net Cash Per Share
-3.410.7849.63114.08271.69346.60

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-37.18-48.2-71.94-104.02-90.42-62.21
Capital Expenditures
----0.1-0.27-0.92
Free Cash Flow
-37.18-48.2-71.94-104.11-90.69-63.14
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-100.00%100.00%--100.00%
Operating Margin
--2965.25%-672.21%---38576.00%
Pretax Margin
--2980.35%-634.33%---38160.80%
Profit Margin
--2980.35%-634.33%---38160.80%
FCF Margin
--2410.20%-653.96%---25255.20%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
2.80900.72156.13--146406.00